Chronic Myeloid Leukemia

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology
Cover of the book Chronic Myeloid Leukemia by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319331980
Publisher: Springer International Publishing Publication: August 17, 2016
Imprint: Springer Language: English
Author:
ISBN: 9783319331980
Publisher: Springer International Publishing
Publication: August 17, 2016
Imprint: Springer
Language: English

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

More books from Springer International Publishing

Cover of the book Psychiatric Care in Severe Obesity by
Cover of the book The Genetics of Type 2 Diabetes and Related Traits by
Cover of the book Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders by
Cover of the book Revision Total Knee Arthroplasty by
Cover of the book Black Rice by
Cover of the book The Paris Agreement by
Cover of the book Contesting Water Rights by
Cover of the book Binding Energy of Strongly Deformed Radionuclides by
Cover of the book Decision Support Systems III - Impact of Decision Support Systems for Global Environments by
Cover of the book The Argentina Continental Margin by
Cover of the book mODa 11 - Advances in Model-Oriented Design and Analysis by
Cover of the book Handbook of Lifelong Learning for Sustainable Development by
Cover of the book Literary Translation and Cultural Mediators in 'Peripheral' Cultures by
Cover of the book Complications of Cirrhosis by
Cover of the book Persuasive Technology: Development and Implementation of Personalized Technologies to Change Attitudes and Behaviors by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy